181 related articles for article (PubMed ID: 37109334)
21. Matched case-control comparison of surgical success after XEN45 Gel Stent and PRESERFLO MicroShunt implantation in a Caucasian population.
Lüke JN; Dietlein TS; Widder RA; Roessler GF; Lüke V; Enders P; Lappa A; Kiessling D
Clin Exp Ophthalmol; 2024 Jun; ():. PubMed ID: 38841836
[TBL] [Abstract][Full Text] [Related]
22. PreserFlo™ MicroShunt Versus Ab Externo Canaloplasty in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Retrospective Study.
Habbe KJ; Kohlhaas M; Fili S
Cureus; 2023 Feb; 15(2):e35185. PubMed ID: 36960244
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature.
Pawiroredjo SSM; Bramer WM; Pawiroredjo ND; Pals J; Poelman HJ; de Vries VA; Wolfs RCW; Ramdas WD
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498729
[TBL] [Abstract][Full Text] [Related]
24. Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.
Triolo G; Wang J; Aguilar-Munoa S; Jayaram H; Barton K
Eye (Lond); 2023 Aug; 37(12):2535-2541. PubMed ID: 36577805
[TBL] [Abstract][Full Text] [Related]
25. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.
Pillunat KR; Herber R; Haase MA; Jamke M; Jasper CS; Pillunat LE
Acta Ophthalmol; 2022 May; 100(3):e779-e790. PubMed ID: 34331505
[TBL] [Abstract][Full Text] [Related]
26. Comparison of subconjunctival microinvasive glaucoma surgery and trabeculectomy.
Wagner FM; Schuster AK; Munder A; Muehl M; Chronopoulos P; Pfeiffer N; Hoffmann EM
Acta Ophthalmol; 2022 Aug; 100(5):e1120-e1126. PubMed ID: 34626093
[TBL] [Abstract][Full Text] [Related]
27. MicroShunt versus Trabeculectomy for Surgical Management of Glaucoma: A Retrospective Analysis.
Fu MX; Normando EM; Luk SMH; Deshmukh M; Ahmed F; Crawley L; Ameen S; Vig N; Cordeiro MF; Bloom PA
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36143128
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
Strzalkowska A; Strzalkowski P; Hoffmann EM; Pfeiffer N; Schuster AK
J Glaucoma; 2023 Aug; 32(8):681-685. PubMed ID: 37327469
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort.
Storp JJ; Vietmeier FE; Merté RL; Koch R; Zimmermann JA; Eter N; Brücher VC
J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445509
[TBL] [Abstract][Full Text] [Related]
30. Ab externo implantation of the MicroShunt, a poly (styrene-
Sadruddin O; Pinchuk L; Angeles R; Palmberg P
Eye Vis (Lond); 2019; 6():36. PubMed ID: 31807606
[TBL] [Abstract][Full Text] [Related]
31. Comparison of long-term results of trabeculectomy and phacotrabeculectomy in patients with pseudoexfoliation glaucoma and primary open-angle glaucoma: a single-center study.
Yilmaz Tugan B; Yuksel N; Kesim E; Subasi S
Int Ophthalmol; 2022 Jun; 42(6):1737-1747. PubMed ID: 35083598
[TBL] [Abstract][Full Text] [Related]
32. Comparing the safety and efficacy of Preserflo Microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis.
Khan A; Khan AU
Acta Ophthalmol; 2024 Jun; 102(4):e443-e451. PubMed ID: 38376121
[TBL] [Abstract][Full Text] [Related]
33. Retrospective Analysis of 12 Months Glaucoma Implant Efficacy: XEN45 and PreserFlo Microshunt.
Saletta G; Alexoudis A; Gatzioufas Z; Grieshaber M; Papazoglou A; Tschopp M; Töteberg M; Gugleta K
Klin Monbl Augenheilkd; 2022 Apr; 239(4):429-434. PubMed ID: 35472784
[TBL] [Abstract][Full Text] [Related]
34. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.
Aghayeva FA; Chronopoulos P; Schuster AK; Pfeiffer N; Hoffmann EM
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3045-3053. PubMed ID: 33963917
[TBL] [Abstract][Full Text] [Related]
35. Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study.
Bhayani R; Martínez de la Casa JM; Figus M; Klabe K; Rabiolo A; Mercieca K
Eye (Lond); 2023 Mar; 37(4):644-649. PubMed ID: 35277663
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation.
Rabiolo A; Toscani R; Sacchi M; Destefanis P; Bettin P; Ciampi C; Clemente A; Cutolo CA; Mercieca K; Iester M; Traverso CE; Di Maita M; Li Calzi G; Nucci P; Bandello F; Triolo G; De Cillà S
Am J Ophthalmol; 2024 Mar; 259():117-130. PubMed ID: 37979601
[TBL] [Abstract][Full Text] [Related]
37. Intraocular Pressure-Lowering Effects of Trabeculectomy Versus MicroShunt Insertion in Rabbit Eyes.
Fujimoto T; Nakashima KI; Watanabe-Kitamura F; Watanabe T; Nakamura K; Maki K; Shimazaki A; Kato M; Tanihara H; Inoue T
Transl Vis Sci Technol; 2021 Aug; 10(9):9. PubMed ID: 34357381
[TBL] [Abstract][Full Text] [Related]
38. Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma.
Ahmed IIK; Sadruddin O; Panarelli JF
Eye Vis (Lond); 2023 Mar; 10(1):10. PubMed ID: 36859515
[TBL] [Abstract][Full Text] [Related]
39. PreserFlo™ MicroShunt Combined with Phacoemulsification versus PreserFlo™ MicroShunt as a Standalone Procedure in Patients with Medically Resistant Open-Angle Glaucoma.
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Bechrakis N; Kohlhaas M
J Curr Ophthalmol; 2022; 34(2):180-186. PubMed ID: 36147269
[TBL] [Abstract][Full Text] [Related]
40. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.
Durr GM; Schlenker MB; Samet S; Ahmed IIK
Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
